Published in Medicine and Law Weekly, June 17th, 2005
"AC9 activity has been shown to be inhibited by PMA activation of novel protein kinase C (nPKC) isoforms. In the current study the effect on AC9 activity of activating PKC in physiological relevant manner was examined," wrote M.G. Cumbay and colleagues, Purdue University.
"Contrary to the anticipated inhibitory effect of activating PKCs through Gq -coupled receptors, activation of transiently expressed G-coupled serotonin 5-HT2A or muscarinic M-5...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.